Sixty Years of CA: A Cancer Journal for Clinicians


  • DISCLOSURES: Dr. Patricia Ganz reports that her husband serves as the Chief Scientific Officer for Intrinsic Life Sciences, and they retain stock in Intrinsic Life Sciences. Dr. Peter Johnstone serves as President/CEO of the Midwest Proton Radiotherapy Institute. Dr. Martin Mahoney serves as a consultant for Merck; he has received research funding from Pfizer, and serves as a member of the speaker's bureau for Merck, Novartis, Pfizer and Sanofi Aventis. Dr. William Oh has served as a consultant for BIND Biosciences, Inc.; Genentech; and Centocor Ortho Biotech, Inc. Dr. Andrew Vickers serves as consultant for Theradex and for GlaxoSmithKline. Dr. Otis Brawley serves as an unpaid medical consultant to GlaxoSmithKline, Sanofi-Aventis, and CNN. The authors report no other conflicts of interest.

  • Available online at and


The first issue of CA: A Cancer Journal for Clinicians was published in November of 1950. On the 60th anniversary of that date, we briefly review several seminal contributions to oncology and cancer control published in our journal during its first decade. CA Cancer J Clin 2010. © 2010 American Cancer Society, Inc.